Literature DB >> 464563

Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component.

J R Egerton, D A Ostlind, L S Blair, C H Eary, D Suhayda, S Cifelli, R F Riek, W C Campbell.   

Abstract

When given to sheep as a single oral dose at 0.1 mg/kg, the B(1a) component of the avermectins caused a reduction of >95% in the numbers of Haemonchus contortus, Ostertagia circumcincta (including inhibited L(4) larvae), Trichostrongylus axei, Trichostrongylus colubriformis, Cooperia oncophora, and Oesophagostomum columbianum. When given to cattle as a single oral dose at 0.1 mg/kg, avermectin B(1a) was >95% effective in reducing the numbers of Haemonchus placei, Ostertagia ostertagi (including inhibited L(4) larvae), T. axei, T. colubriformis, C. oncophora, Cooperia punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus. Avermectin B(1a) was similarly effective, with the exception of a detectable loss in activity against adult C. oncophora, when administered to cattle as a parenteral injection. Some of these ruminant parasites were fully susceptible to dosages of avermectin B(1a) at 0.025 mg/kg, e.g., D. viviparus, O. radiatum, O. ostertagi, and H. contortus. Avermectin B(1a) removed 83 to 100% of Ancylostoma caninum from dogs given a single oral dose of 0.003 to 0.005 mg/kg. The poultry nematodes Capillaria obsignata and immature Ascaridia galli were effectively removed by avermectin B(1a) at 0.05 and 0.1 mg/kg, respectively, but 0.1 mg/kg was not effective for Heterakis gallinarum. Thus, the avermectins would appear to have unprecedented potency and spectrum of biological activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464563      PMCID: PMC352668          DOI: 10.1128/AAC.15.3.372

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  The effect of hygromycin B on the migrating larvae of Ascaris suum.

Authors:  G W KELLEY; L S OLSEN
Journal:  J Am Vet Med Assoc       Date:  1959-03-15       Impact factor: 1.936

2.  Critical tests of hygromycin B as an ascaricide of swine.

Authors:  G W KELLEY; L S OLSEN
Journal:  Cornell Vet       Date:  1960-01

3.  Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties.

Authors:  T W Miller; L Chaiet; D J Cole; L J Cole; J E Flor; R T Goegelman; V P Gullo; H Joshua; A J Kempf; W R Krellwitz; R L Monaghan; R E Ormond; K E Wilson; G Albers-Schönberg; I Putter
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

4.  Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Authors:  R W Burg; B M Miller; E E Baker; J Birnbaum; S A Currie; R Hartman; Y L Kong; R L Monaghan; G Olson; I Putter; J B Tunac; H Wallick; E O Stapley; R Oiwa; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

  4 in total
  53 in total

1.  Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis.

Authors:  Ying Zhuo; Wenquan Zhang; Difei Chen; Hong Gao; Jun Tao; Mei Liu; Zhongxuan Gou; Xianlong Zhou; Bang-Ce Ye; Qing Zhang; Siliang Zhang; Li-Xin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine.

Authors:  Wesley C Van Voorhis; Rob Hooft van Huijsduijnen; Timothy N C Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

3.  Involvement of glucose catabolism in avermectin production by Streptomyces avermitilis.

Authors:  H Ikeda; H Kotaki; H Tanaka; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

4.  Effect of ivermectin on weight gains on yearling steers on pasture in central Alberta.

Authors:  M J Kennedy; D R Zobell; L Goonewardene
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

5.  Increasing Avermectin Production in Streptomyces avermitilis by Manipulating the Expression of a Novel TetR-Family Regulator and Its Target Gene Product.

Authors:  Wenshuai Liu; Qinling Zhang; Jia Guo; Zhi Chen; Jilun Li; Ying Wen
Journal:  Appl Environ Microbiol       Date:  2015-05-22       Impact factor: 4.792

Review 6.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 7.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

8.  Directed evolution of glycosyltransferase for enhanced efficiency of avermectin glucosylation.

Authors:  Ha-Young Choi; Hyun Seung Lim; Kwang-Hyun Park; Junheon Kim; Won-Gon Kim
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-27       Impact factor: 4.813

9.  Efficacy of abamectin injection against Dermatobia hominis in cattle.

Authors:  J B Cruz; C Benitez-Usher; L G Cramer; S J Gross; A B Kohn
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

10.  Avermectin B1a, a paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris.

Authors:  I S Kass; C C Wang; J P Walrond; A O Stretton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.